MedTrace Logo

Effect of Emotion-Focused Acceptance and Commitment Therapy on Obsessive-Compulsive Disorder Symptom Severity

NCT07622654 · Status: RECRUITING · Phase: NA · Type: INTERVENTIONAL · Enrollment: 36

Last updated 2026-06-03

No results posted yet for this study

Summary

This study aims to investigate the effect of Emotion-Focused Acceptance and Commitment Therapy (ACT) group psychotherapy on obsessive-compulsive disorder (OCD) symptom severity. Participants with OCD will be randomly assigned to either an ACT-based group psychotherapy arm or a supportive group psychotherapy arm. Each arm consists of 10 to 12 weekly sessions of 2 hours. Symptom severity, psychological flexibility, emotional awareness, functioning and quality of life will be assessed before and after the intervention.

Conditions

  • OCD
  • Obsessive - Compulsive Disorder

Interventions

BEHAVIORAL

Emotion-Focused Acceptance and Commitment Therapy (ACT) Group Psychotherapy

Structured group psychotherapy based on ACT principles targeting emotional awareness, acceptance of emotional experiences, cognitive defusion, present-moment focus, values clarification and committed action. Sessions are conducted face-to-face, once weekly, 2 hours per session, for 10-12 weeks.

Sponsors & Collaborators

  • Goztepe Prof Dr Suleyman Yalcın City Hospital

    collaborator OTHER

  • Mehmet Emrah Karadere

    lead OTHER

Principal Investigators

  • Mehmet Emrah Karadere · Goztepe Prof Dr Suleyman Yalcın City Hospital

  • Kaasım Fatih Yavuz · Baglamsal Bilimler ve Psikoterapiler Dernegi

  • Beyza Baran Boz · Goztepe Prof Dr Suleyman Yalcın City Hospital

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
NONE
Model
PARALLEL

Eligibility

Min Age
18 Years
Max Age
65 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2025-10-01
Primary Completion
2026-06-01
Completion
2026-06-01

Countries

  • Turkey (Türkiye)

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT07622654 on ClinicalTrials.gov